When a tragedy like the Sept. 11 attacks or the Virginia Tech shooting strikes, shock and grief quickly give way to blame. And when it's time to figure out if and how victims should be compensated, lawyer Kenneth Feinberg's phone rings.
Over the past three decades, Feinberg has developed a unique specialty: overseeing compensation funds by doing the difficult, often contentious and politically charged work of figuring out who deserves payment — and often, how much they will receive.
We don't know what this says about the relationship between humans and robots. But researchers at the Ishikawa Oku Lab at the University of Toyko have developed a robot hand that can beat a human 100 percent of the time in a game of "rock, paper, scissors."
The biggest surprise Thursday morning at the Supreme Court will be if the justices do not issue their most-anticipated decision of the year — on the constitutionality of the Affordable Care Act; the health care overhaul enacted in 2010.
The FDA gave the green light to Arena Pharmaceuticals to sell Belviq, or lorcaserin generically, a twice-a-day pill that suppresses appetite and appears to affect metabolism by influencing levels of the brain chemical serotonin.